Income Statement

HARMONY BIOSCIENCES HOLDINGS, INC.

HRMY
Annual
Performance Overview Click any row in the table to add it to this chart
in millions USD
Metric Dec 31, 2025 2025 FY Dec 31, 2024 2024 FY Dec 31, 2023 2023 FY Dec 31, 2022 2022 FY Dec 31, 2021 2021 FY Dec 31, 2020 2020 FY
Revenue
868.45 714.73 582.02 437.86 305.44 159.74
Cost of Revenue
198.34 156.82 121.24 83.48 55.52 27.74
Gross Profit
670.11 557.92 460.79 354.37 249.92 132.00
Operating Expenses
461.64 367.09 268.76 234.19 162.39 115.02
Research & Development
189.59 145.83 76.06 70.89 30.37 19.45
Selling, General & Administrative
152.54 110.92 97.40 84.02 68.12 55.82
Other Operating Expenses
- - - - - -
Operating Income
208.47 190.83 192.03 120.19 87.53 16.99
Non-Operating Income
-6.60 -0.98 18.63 15.50 50.10 53.93
Interest Income
- - - - - -
Interest Expense
14.65 17.50 23.76 18.80 24.19 28.62
Other Non-Op Income / Expense
-0.68 -0.07 0.16 0.17 0.02 -3.07
Income Before Tax
215.06 191.80 173.40 104.69 37.43 -36.94
Income Tax Expense
56.38 46.31 44.54 -76.78 2.83 0.00
Non-Controlling Interest
- - - - - -
Net Income
158.69 145.49 128.85 181.47 34.60 -36.94
Supplemental Per share data, derived & other items — not part of the income statement
in millions USD unless noted
Metric Dec 31, 2025 2025 FY Dec 31, 2024 2024 FY Dec 31, 2023 2023 FY Dec 31, 2022 2022 FY Dec 31, 2021 2021 FY Dec 31, 2020 2020 FY
Depreciation & Amortization
- - - - - -
EBITDA
208.47 190.83 192.03 120.19 87.53 16.99
Earnings Per Share (Basic)
2.76 2.56 2.17 3.07 0.60 -2.48
Diluted EPS
2.71 2.51 2.13 2.97 0.58 -2.48
Weighted Average Shares
57.49 56.89 59.47 59.17 57.53 25.77
Diluted Weighted Avg Shares
58.54 57.87 60.37 61.10 59.21 25.77
Comprehensive Income
158.97 145.56 129.01 181.32 - -